[1] 顾文莉,张雪玉,张丽,等.克龄蒙治疗妇女围绝经期综合征的临床疗效观察[J].宁夏医科大学学报,2014,36(4):424-426. [2] 李瑞珠.探究坤泰胶囊联用雌激素替代疗法治疗围绝经期综合征临床疗效[J].中医药学报,2014,1(3):146-148. [3] Vogel NE,Bmgge HG,G raaf JC,et al.Tamoxifen:does a wider ranger ofindications require more careful monitoring[J].Ned Tijdschr Gmeeskd,2015,145(22):1041-1043. [4] 周华锋.地屈孕酮联合坤泰胶囊治疗女性更年期综合征的临床研究[J].中国妇幼保健,2014,29(21):3390-3392. [5] 肖枝兰.激素替代治疗对围绝经期综合征的症状改善程度及不良反应分析[J].中国妇幼保健,2014,29(29):4852-4853. [6] 张荣环.心理护理对女性围绝经期综合征患者不良情绪及睡眠障碍的影响研究[J].检验医学与临床,2014,1(4):534-536. [7] 李丽.坤泰胶囊与雌激素治疗围绝经期综合征的疗效比较[J].检验医学与临床,2015,1(15):2241-2242. [8] Tunan C,Unal O,Dansuk R,et al.Successful management of an ovarian enlargement resembling ovarian hyperstimulation in a premenopausal breast cancer patient receiving tamoxifen with cotreatment of GnRH-agonist[J].Eur J Obstet Gynecol Reprod Biol,2014,97(1):105-107. [9] 李长滨.(围)绝经期综合征患者激素替代治疗依从性及其影响因素分析[J].山东医药,2014,1(18):49-50. [10] 冯巍,史惠蓉,贾艳艳.激素治疗绝经综合征早期患者的依从性及其影响因素分析[J].中华老年医学杂志,2016,35(7):732-735. [11] Neven P,Goldstein SR,Ciaccia AV,et al.The effect of raloxifene on the incidence of ovarian cancer in postmenopausal women [J].Gynecol Oncol,2014,85(2):388-390. [12] 马堃,陈燕霞.中西医治疗围绝经期综合征策略的探讨[J].中国中药杂志,2015,40(20):3899-3906. [13] Lippman IE,Krueger KA,Ecken S,et al.Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants[J].J Clin Oncol,2014,19(12):3111-3116. [14] 洪翠华,严育宏,柯晓娟,等.围绝经妇女激素替代后生命质量的变化[J].中国性科学,2014,1(12):3-5. [15] Kloosterboss HJ,Ederreen AG.Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone,SERMs and estrogen (+/-progestogen) treatments[J].J Steroid Biochem Mol Biol,2002 ,83(1-5):157-165.
2018, Vol. 35 
